Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress his Department has made on research on the efficacy of (a) monoclonal antibodies and (b) other alternative treatments for immunocompromised and immunosuppressed groups.
The National Institute for Health Research (NIHR) has supported 15 studies on monoclonal antibodies and other therapies for immunocompromised and immunosuppressed groups, including cell therapy and the use of probiotics. Twelve of these studies are now complete and three are ongoing. All NIHR-funded research is expected to be published in peer-reviewed, open access journals once completed to promote translation into patient care where appropriate.